Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
01/1997
01/01/1997CN1139382A Modified-release metronidazole compositions and methods for making and using same
01/01/1997CN1139381A Detection of H. pylori in the stomach
01/01/1997CN1139380A Controlled release preparation
01/01/1997CN1139379A Novel method of the manufacture of suppositories
01/01/1997CN1139375A Biocompatible ocular implants
01/01/1997CN1139116A Radioactive chitosan complex, its macroaggrgate and kit for preparing radioactive chitosan complex, process for preparation thereof, and use thereof for radiation therapy
01/01/1997CN1139110A Inhibitng photodecomposition of 3-substituted-2-oxindoles
01/01/1997CN1139003A Pulekang injection for curing cancer
01/01/1997CN1139001A Antiphthitic medicine
01/01/1997CN1139000A Medicine for diabetes
01/01/1997CN1138997A Analgesic and its prepn
01/01/1997CN1138996A Chinese medicine ointment for bone tuberculosis
01/01/1997CN1138995A Rehabilitation liquid for allergic rhinitis and ophthalmitis
01/01/1997CN1138993A Tobacco additive with the function of improving health and curing diseases
01/01/1997CN1138986A Medicinal bezoar-Radix notoginseng powder for viginal disease and its preparation
01/01/1997CN1138954A Caries preventing and tooth cleaning chewing gum
12/1996
12/31/1996US5589510 Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound
12/31/1996US5589508 Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases
12/31/1996US5589498 Plasticizing and solvent type enhancers, porous membranes, hydrogels, foams
12/31/1996US5589491 Injection and injection kit containing omeprazole and its analogs
12/31/1996US5589466 Induction of a protective immune response in a mammal by injecting a DNA sequence
12/31/1996US5589455 Cyclosporin-containing soft capsule compositions
12/31/1996US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/31/1996US5589195 Film-forming proteinaceous emulsion
12/31/1996US5589194 Dispersion of active material in matrix and solidification
12/31/1996US5589192 Gel pharmaceutical formulation for local anesthesia
12/31/1996US5589191 Slow-release sodium valproate tablets
12/31/1996US5589190 Sustained-release compositions of alfuzosin hydrochloride
12/31/1996US5589189 Liposome dispersion
12/31/1996US5589187 Protective encapsulation of micronutrients for ingestion by avian species
12/31/1996US5589185 Nonsteroidal antiinflammatory agents
12/31/1996US5589184 Pharmaceutical compositions and methods of treatment of the cornea following laser treatment
12/31/1996US5589182 Aqueous extracts of tissue of specific chinese plants and herbs
12/31/1996US5589180 Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
12/31/1996US5589178 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof
12/31/1996US5589169 Topical application of tissue plasminogen activator
12/31/1996US5589167 Excipient stabilization of polypeptides treated with organic solvents
12/31/1996US5589156 Prilocaine and hydrofluourocarbon aerosol preparations
12/31/1996CA2180206A1 Freeze-dried preparation for pharmaceutical use
12/31/1996CA2054752C Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
12/31/1996CA1338819C Transdermal estradiol delivery system
12/30/1996EP0732911A4 Optionally crosslinkable coatings, compositions and methods of use
12/27/1996WO1996041987A2 High pressure gas exchanger
12/27/1996WO1996041873A1 Dry powder formulations of polynucleotide complexes
12/27/1996WO1996041818A1 Chitin hydrogels, methods of their production and use
12/27/1996WO1996041647A1 Site specific binding system, imaging compositions and methods
12/27/1996WO1996041646A2 Pharmaceutical compositions containing lornoxicam and cyclodextrin
12/27/1996WO1996041642A1 Stable freeze-dried composition containing tpo
12/27/1996WO1996041632A1 Starch microsphere anti migraine composition
12/27/1996WO1996041628A1 Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast
12/27/1996WO1996041623A2 Tricot-like pouch for the delivery of topical drugs and cosmetics
12/27/1996WO1996041622A1 Soft gelatin capsules containing particulate material
12/27/1996WO1996041621A2 Osmotic-delivery devices having vapor-permeable coatings
12/27/1996WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996WO1996041619A1 Controlled release of drugs delivered by sublingual or buccal administration
12/27/1996WO1996041618A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/27/1996WO1996041617A1 Solid pharmaceutical form for oral use
12/27/1996WO1996041616A1 Formulations and methods for providing prolonged local anesthesia
12/27/1996WO1996041615A2 In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product
12/27/1996WO1996041523A1 Fgf9 as a specific ligand for fgfr3
12/27/1996WO1996021731A3 Stabilized external guide sequences
12/27/1996EP0749753A2 Use of a powder or an extract of guava for treating allergic diseases
12/27/1996EP0749751A2 Pharmaceutical composition for use in tteatment of diabetes
12/27/1996EP0749747A1 Composition contenant a dispersion of polymer particles in a non aqueous medium
12/27/1996EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION
12/27/1996EP0749474A1 Microfabricated capsules for isolation of cell transplants
12/27/1996EP0749447A1 Water-soluble dextran fatty acid esters and their use as solubilisers
12/27/1996EP0749324A1 Veterinary formulation
12/27/1996EP0749308A1 Film coated tablet of paracetamol and domperidone
12/27/1996EP0749304A1 Slow-release tablet containing diclofenac-na
12/27/1996EP0749303A1 Method of treating disorders of the eye
12/27/1996EP0749301A1 Adhesive free topical pharmaceutical formulations
12/27/1996EP0749300A1 Pharmaceutical excipient having improved compressibility
12/27/1996EP0749277A1 Coprocessed galactomannan - glucomannan
12/27/1996EP0680326B1 Pharmaceutical composition for treating nicotine dependence
12/27/1996CA2224267A1 Solid pharmaceutical form for oral use
12/27/1996CA2224253A1 Chitin hydrogels, methods of their production and use
12/27/1996CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996CA2224156A1 Dry powder formulations of polynucleotide complexes
12/27/1996CA2224101A1 High pressure gas exchanger
12/27/1996CA2223768A1 Suspension and soft gelatin capsules containing particulate matter
12/27/1996CA2223749A1 Stable tpo-containing lyophilized compositions
12/27/1996CA2223568A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/25/1996CN2243299Y Scopolamine dressing for controllable release on belly
12/25/1996CN2243298Y Fast acting analgesic dressing for oncoma
12/25/1996CN1138828A Prepn. of hollow microcapsules
12/25/1996CN1138827A Process for solubilizing difficultly soluble pharmaceutical actives
12/25/1996CN1138826A Microgranules of 5-nitro imidazole derivatives
12/25/1996CN1138482A Medicine and bone-growing plaster for treatment of fracture
12/25/1996CN1138477A Chinese medicinal preparation for treatment skin disease and its prepn. method
12/25/1996CN1138474A Antissepsis, antiinflammation and hemostasis capsules
12/25/1996CN1138472A Presciption and prepn. technique of "Ruzengning", for treatment of hyperplasia of mammary glands
12/25/1996CN1138471A Medicinal liquid for treatment burn, scald and skin ulcer
12/25/1996CN1138462A Foetus umbilical serum eyedrops and its application
12/25/1996CN1138456A Transparent ultramicro oil water emulsion using fluid non-ion amphiphilic lipid as main component and its applications in cosmetics and skin medicine
12/25/1996CN1138437A Medicinal tobacco leaf and its prepn. method
12/24/1996US5587366 Compositions useful in prophylaxis and therapy of endotoxin related conditions
12/24/1996US5587199 Suspending in aqueous phase magnetite iron oxide particles, amphipathic phosphoric acid ester, nonionic surfactant; sonicating, microfluidizing or heating to organize amphipathic compound into three-dimensional structure
12/24/1996US5587180 Comprising a non-hydrolyzed and a hydrolyzed gelatin with a bulking agent; evaporation of solvent and volatilizing agent from drops in heated drying chamber; expansion
12/24/1996US5587179 Pharmaceutical formulation in the form of an effervescent and/or disintegrating tablet or of instant granulate, and process for their preparation